尿路上皮癌膀胱药物灌注致重度膀胱功能损害的碱化利多卡因灌注治疗

黄英; 魏辉; 程志刚; 李国; 罗旭杰; 方少洪; 梅骅

尿路上皮癌膀胱药物灌注致重度膀胱功能损害的碱化利多卡因灌注治疗

- 深圳中山泌尿外科医院(广东深圳, 518045)

详细信息

通讯作者: 黄英,E-mail:13798381635@163.com

中图分类号: R737.15

收稿日期: 2012-04-17

Distensible intravesical instillation of alkalinizedlidocaine in the treatment of drug-induced severe bladder dysfunction after post-operative of urothelial carcinoma with intravesical instillation

- Shenzhen Zhongshan Urological Hospital, Shenzhen, Guangdong, 518045, China

More Information

Corresponding author: HUANG Ying, E-mail: 13798381635@163.com

Received Date: 17 April 2012

摘要

摘要: 目的：评价碱化利多卡因扩张性灌注治疗尿路上皮癌膀胱灌注后药物相关性重度膀胱损害的疗效与安全性。方法：对6例尿路上皮癌患者因行吡柔比星、丝裂霉素及BCG灌注引起的重度膀胱损害，其中3例为灌注BCG行三联抗结核药物等综合治疗无效而被迫放弃、中止治疗者，采用膀胱镜检后碱化利多卡因扩张性灌注方法进行治疗，并评估治疗前、后下尿路症状及其相关指标。结果：6例患者下尿路症状及评分、膀胱容量流率、膀胱敏感性明显改善，并完全恢复原来的化学药物灌注。平均随访10（3~16）个月，无膀胱损害症状复发，效果满意。结论：应用碱化利多卡因扩张性灌注治疗尿路上皮癌膀胱灌注后药物相关性重度膀胱损害，是有效和安全的，可恢复尿路上皮癌患者行膀胱灌注药物的耐受依从性。
- 碱化利多卡因 /
- 扩张性灌注 /
- 膀胱损害 /
- 尿路上皮癌
Abstract: Objective: To evaluate the safety and efficacy of distensible intravesical instillation of alkalinizedlidocaine in the treatment of drug-induced severe bladder dysfunction of urothelial carcinoma with intravesical instillation,and improve compliance of them.Method: Six cases of severe bladder dysfunction with intravesical instillation of THP,MMC,BCG who experienced of long-term antibiotics and M-receptor blockage isineffective and was forced to give up.All patients were treated with distensible intravesical instillation of alkalinizedlidocaine, assessed before treatment and after treatment of lower urinary tract symptom score, voiding diary, urodynamic examination (bladder capacity,urinary flow rate,residual urine,bladder sensitivity).Result: Lower urinary tract symptoms,bladder capacity,sensitivity in the six cases of drug-induced severe bladder injury patients were significantly improved. With the follow-up of 10(3-16) months, the effect is satisfied.Conclusion: Distensible intravesical instillation of alkalinizedlidocaine in the treatment of drug-induced severe bladder dysfunction after post-operative of urothelial carcinoma with intravesical instillation is an effective,safe and feasible procedure.
- alkalinizedlidocaine /
- distensible intravesical instillation /
- bladder dysfunction /
- urothelial carcinoma

HTML全文

参考文献(13)

[1]	BABJUK M, OOSTERLINCK W, SYLVESTER R, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update[J]. Eur Urol, 2011, 59:997-1008.
[2]	BRANCHEREAU J, LUYCKX F, HITIER M, et al. Bladder necrosis after an immediate post-operative mitomycin C instillation[J]. Prog Urol, 2011, 21:151-153.
[3]	MACÍA VILLA C, SIFUENTES GIRALDO W, Boteanu A, et al. Reactive arthritis after the intravesical instillation of BCG[J]. Reumatol Clin, 2012, 8:201-207.
[4]	MIRANDA S, VERDET M, HÉRON F, et al. Acute reactive arthritis afterintravesical instillationof bacillus Calmette-Guérin. Two case reports and literature review[J]. Rev Med Interne, 2010, 31:558-561.
[5]	PARSONS C L, ZUPKAS P, PROCTOR J, et al. Alkalinized lidocaine and heparin provide immediate relief of pain and urgency in patients with interstitial cystitis[J]. J Sex Med, 2012, 9:207-212.
[6]	MATSUO T, SHIDA Y, HAYASHIDA Y, et al. Intravesical therapy of heparin and lidocaine for interstitial cystitis:a case report[J]. Hinyokika Kiyo, 2011, 57:513-516.
[7]	NICKEL J C, MOLDWIN R, LEE S, et al. Intravesical alkalinized lidocaine(PSD597)offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome[J]. BJU Int, 2009, 103:910-918.
[8]	魏辉, 黄英, 张晓忠, 等. 碱化利多卡因膀胱灌注治疗氯胺酮相关性膀胱炎[J]. 中华泌尿外科杂志, 2010, 31(9):621-623.
[9]	KUO H C, CHANCELLOR M B. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome[J]. BJU Int, 2009, 104:657-661.
[10]	HSIEH C H, CHANG S T, HSIEH C J, et al.Treatment of interstitial cystitis with hydrodistention and bladder training[J]. Int Urogynecol J Pelvic Floor Dysfunct, 2008, 19:1379-1384.
[11]	HERR H W. Intravesical bacillus Calmette-Guérin outcomes in patients with bladder cancer and asymptomatic bacteriuria[J]. J Urol, 2012, 187:435-437.
[12]	SHELLEY M D, JONES G, CLEVES A, et al. Intravesical gemcitabine therapy for non-muscle invasive bladder cancer(NMIBC):a systematic review[J]. BJU Int, 2012, 109:496-505.
[13]	XIAO Z, HANEL E, MAK A, et al. Antitumor Efficacy of Intravesical BCG, Gemcitabine, Interferon-α and Interleukin-2 as Mono- or Combination-Therapy for Bladder Cancer in an Orthotopic Tumor Model[J]. Clin Med Insights Oncol, 2011, 5:315-323.